share_log

Ocular Therapeutix Q1 2024 Adj EPS $(0.28) Misses $(0.19) Estimate, Sales $14.774M Miss $15.414M Estimate

Benzinga ·  May 7 16:48

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.19) by 47.37 percent. The company reported quarterly sales of $14.774 million which missed the analyst consensus estimate of $15.414 million by 4.15 percent. This is a 10.47 percent increase over sales of $13.374 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment